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Abstract
Background: Cigarette smoking-induced oxidative stress is known to be a key mechanism in COPD pathogenesis.
Nuclear factor erythroid 2-related factor 2 (Nrf2) is a central transcription factor that regulates the antioxidant
defense system. The aim of this study was to compare Nrf2 expression in COPD subjects and control subjects, and
to determine the role of Nrf2 in protecting against oxidative stress-induced apoptosis.
Methods: We enrolled 8 COPD subjects and 7 control subjects in this study. We performed bronchial brushing by
bronchoscopy and obtained bronchial epithelial cells from the airways. Nrf2 expression in bronchial epithelial cells
was evaluated by real-time PCR and Western blotting. We examined the effect of 10 or 15 % cigarette smoke extract
(CSE) induced A549 cells apoptosis using a time-lapse cell imaging assay with caspase-3/7 activation detecting reagent
and performed Terminal deoxynucleotidyltransferase-mediated dUTP nick end labelling assay for confirming A549 cells
apoptosis. We also examined the effects of Nrf2 knockdown and, 0.1, 0.5, and 1.0 mM N-acetyl cysteine on CSE-induced
apoptosis. Statistical analyses were performed using t-test, paired t-test or an analysis of variance followed by the
Tukey-Kramer method.
Results: Nrf2 mRNA expression in COPD subjects was significantly lower than that in control subjects and Nrf2 mRNA
were negatively correlated with pack year. Nrf2 protein in COPD subjects was significantly lower than that in control
subjects. CSE-induced A549 cells apoptosis was increased in a time-, concentration-dependent manner, and was
significantly increased by Nrf2 knockdown. N-acetyl cysteine significantly ameliorated CSE-induced apoptosis.
Conclusions: Nrf2 expression was lower in COPD patients than in control subjects. Nrf2 might have a protective role
against apoptosis caused by CSE-induced oxidative stress. These results suggest an involvement of Nrf2 in COPD and
administration of antioxidants to patients with COPD might be a basic therapeutic option.
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Background
Chronic obstructive pulmonary disease (COPD) is pro-
jected to become the third most prevalent cause of mor-
tality in the world by 2020 [1], and it is a major concern
in terms of health economics. Although COPD is de-
fined and categorized by limitations in airflow, it is not a
single disease. Pathological changes in COPD include
changes in the central or distal airways. The former is
considered chronic bronchitis, and this disease is accom-
panied by an influx of inflammatory cells in the mucosa
and airway remodeling, such as epithelial metaplasia and
mucus hypersecretion due to hyperplasia of subepithelial
mucus glands or goblet cells. The latter is considered
emphysema, and alveolar wall destruction and disrupted
alveolar attachments to small airway walls are seen with
this condition. Inhalation of noxious gas is known to
cause COPD, and cigarette smoking, specifically, is rec-
ognized as the major cause of COPD. Cigarette smoke
has a gas component and a small particulate matter
component of less than 5 μm, and with inhaled cigarette
smoke, these components will reach the small airways
and evoke pathological changes in the alveolar walls.
Oxidative stress is now recognized as a major predispos-
ing factor in the pathogenesis of COPD. Cigarette smoke
contains reactive oxygen species (ROS) and each puff of
tobacco smoke contains approximately 1x1017 oxidant
molecules [2]. ROS can cause oxidative stress and play a
major role in cell apoptosis through injury induced by
cigarette smoke [3]. Excessive loss of alveolar epithelial
cells and endothelial cells by apoptosis has been postu-
lated to lead to the destruction of lung tissue and
emphysema.
Nuclear factor erythroid 2-related factor 2 (Nrf2), also
known as NFE2L2, is ubiquitously expressed at high
concentrations in various human organs including the
lungs. Although Nrf2 exists in the cytoplasm with a clus-
ter of proteins that degrade it quickly under normal con-
ditions, following oxidative stress, Nrf2 reaches the
nucleus of a cell and binds to the antioxidant response
element (ARE) in the upstream promoter region of
antioxidant genes and initiates transcription of these
genes and expression of these proteins [4]. Nrf2 is a
central transcription factor that regulates the antioxi-
dant defense system and acts as a modifier of several
lung diseases associated with oxidative stress and in-
flammation. Murine studies report that the knockdown
of Nrf2 made mice highly susceptible to cigarette smoke-
induced lung injury [5, 6]. Moreover, Nrf2 activation in
macrophages reduced oxidative stress [7]. These studies
suggest that there is a clear link between defects in the
lung antioxidant defense system regulated by Nrf2 and
oxidative stress-related lung diseases [8]. However, in
humans, no previous studies have addressed the relation-
ship of Nrf2 expression to oxidative stress and COPD.
In this study, we determined the level of Nrf2 in the
bronchial epithelial cells by RT-PCR and Western blot-
ting, and alveolar epithelial cells by immunohistochemis-
try in COPD subjects. We also examined the effect of
antioxidants and Nrf2 expression on CSE-induced apop-
tosis in vitro.
Methods
Human bronchial epithelial cells
Study subjects were patients scheduled for bronchosco-
pies for small nodules or a small amount of bloody spu-
tum in an outpatient clinic at Osaka City University. We
performed bronchial brushing from the normal side by
bronchoscopy and obtained bronchial epithelial cells
from the airways of 8 COPD subjects and 7 healthy con-
trol (CTL) subjects. COPD is defined by The Global Ini-
tiative for Chronic Obstructive Lung Disease (GOLD)
guidelines as a post-bronchodilator FEV1 % (FEV1/FVC)
of <70 % [9]. This study was approved by the ethics
committee of Osaka City University Hospital (approval
number 1819) and all patients gave written informed
consents for their participation.
Real-time PCR
Total RNA was extracted using 500 μL of TRIzol (Life
Technologies Japan, Tokyo, Japan) from cells obtained
by bronchoscopic bronchial brushing. Reverse transcrip-
tion of 1 μg of total RNA was performed using Ready-
To-Go T-Primed First-Strand Kit (GE Healthcare Japan,
Tokyo, JAPAN) . One μL of sample cDNA was added to
a PCR mixture containing 1 μL of primers targeting
Nrf2 and GAPDH by TaqMan® Gene Expression Assays
(Life Technologies Japan, Tokyo, Japan), 10 μL of 2×
Universal PCR Master Mix (Life Technologies Japan,
Tokyo, Japan), and 8 μL of DEPC Water. Quantitative
real-time PCR was performed using an Applied Biosys-
tems 7500 Real-Time PCR System (Life Technologies
Japan, Tokyo, Japan). The PCR conditions used in all re-
actions were: 10 min at 95 °C, followed by 40 two-step
cycles (95 °C for 15 s and 60 °C for 45 s). The relative
levels of Nrf2 mRNA were normalized to GAPDH
mRNA using the ΔΔCt method.
Western blotting and detection
Cells obtained by bronchoscopic bronchial brushing
were suspended in 4 ml of PBS. The PBS were centri-
fuged at 10,000 × g at 4 °C for 10 min. Supernatants were
discarded and pellet was dissolved with 100 μL of cell
lysis buffer (Cell Signaling Technology, Danvers, MA,
USA) The concentrations of the resulting protein extracts
were measured using a BCA Protein Assay Kit (Pierce,
Waltham, MA, USA). Ten μg of each total protein lysate
was subjected to sodium dodecyl sulfate polyacrylamide
gel electrophoresis by using Mini-PROTEAN® TGX™
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Precast Protein Gels (4561023, Bio-Rad, Hercules, Califor-
nia, USA). The membranes were incubated at 4 °C over-
night with primary antibodies against Nrf2 (1:250,
ab137550, Abcam, Tokyo, Japan) or β-actin (1:5000, sc-
130656, Santa Cruz Biotechnology, Santa Cruz, CA, USA)
and were then incubated with secondary antibodies against
rabbit IgG produced in goat (sc-2004, Santa Cruz Biotech-
nology) for 2 h at room temperature. The densitometry to
measure protein level in Nrf2 and β-actin was performed
by using LAS4000 (Fuji Imaging, Tokyo, Japan).
Immunohistochemistry
Four COPD and four control subjects formalin-fixed,
paraffin-embedded lung sections (4 μm thick) were ob-
tained from tissue bank of Osaka City University. For
immunohistochemical staining of Nrf2, the usual avidin-
biotin complex (ABC) method was employed. Briefly,
after deparaffinized, the slides were washed with PBS.
The slides were permeabilized with 0.2 % triton (Sigma
Aldrich, St.Louis, MO, USA) in PBS and treated with
5 % hydrogen peroxide in PBS for 30 min at room
temperature. The sections were then blocked with 5 %
goat serum for 30 min, washed with PBS and incubated
overnight with the Nrf2 primary antibody (Santa Cruz
Biothechnology, Santa Cruz, CA, USA) at a dilution of
1:100 at 4 °C. The Vectastain ABC elite kit (Vector La-
boratories, Burlingame, CA, USA) was used to detect
the resulting immune complexes following the manufac-
turer’s instruction. The peroxidase activity was visualized
by using DAB Substrate Kit (SK-4100, Vector Laborator-
ies, Burlingame, CA, USA). The slides were then coun-
terstained with hematoxylin and mounted. Negative
controls were performed using nonimmune serum in-
stead of the primary antibody to exclude nonspecific
staining. For evaluation of immunoperoxidase staining,
two observers blind to clinical information counted
immunoperoxidase staining positive alveolar epithelial
cells in four non-overlapping fields. Total alveolar septal
length of each field was measured by using Image J soft-
ware (National Institutes of Health, Bethesda, Maryland,
USA) and immunoperoxidase positivity of alveolar epi-
thelial cells were adjusted by total alveolar septum
length. We calculated the ratio: positive cell number/al-
veolar septal length.
Preparations of cigarette smoke extract (CSE)
To mimic cigarette smoking-induced epithelial cell dam-
age, we employed the gas phase of CSE in an in vitro
study. CSE was prepared as previously described [10].
Briefly, 40 Marlboro cigarettes (Philip Morris Japan,
Tokyo, Japan) were mounted for burning, and the main
stream of the smoke was aspirated at a flow rate of
1.05 l/min, which was strictly regulated by the
KOFLOCTM Mass Flow Controller (model 8500 series:
Kojima Instruments Inc., Kyoto, Japan) and passed
through a Cambridge glass fiber filter (Heinr, Borgwaldt
GmbH, Hamburg, Germany) to remove the tar phase of
the smoke and nicotine. The remaining gas phase of the
smoke was bubbled into 10 ml of PBS at 25 °C. The
medium was filtered with a 0.22 μm Millex filter (Merck
Millipore, Billerica, MA, USA). This solution was de-
fined as 100 % CSE. The CSE was stored at −80 °C be-
fore use. CSE was diluted with PBS or cell culture
medium for in vitro experiments.
Exhaled breath condensate (EBC)
To examine the oxidative milieu in smokers’ airways,
EBC was collected using ECoScreen® (Eric Jaeger, Würz-
burg, Germany). Fifteen minutes of oral EBCs were col-
lected before and after cigarette smoking in healthy
smoking volunteers without nose clips. The EBC pH
was an easily measurable surrogate marker of oxidative
stress in the airway [11] that was measured immediately
after collection using a pH analyzer (Horiba, Ltd, Kyoto,
Japan).
A549 cell culture
Cigarette smoke induces alveolar cell apoptosis leading
to alveolar wall destruction and emphysema. Therefore,
we employed A549 cells derived from adenocarcinomic
human alveolar basal epithelial cells for in vitro experi-
ments. A549 cells were obtained from American Type
Culture Collection and was grown in DMEM/F12
medium (Lonza Japan, Tokyo, Japan) supplemented with
10 % fetal bovine serum (FBS) on 75 cm2 cell flasks.
Cells were grown to >80 % confluence and passaged to a
96-well plate (Corning 3596, Sigma-Aldrich Japan,
Tokyo, Japan) at a density of 1.67 × 103 cells per well in
triplicate, such that the next day, cells were approxi-
mately 10–20 % confluent. For the time-lapse cell im-
aging assay, treatment and pretreatment media were
prepared as follows. We prepared optimal concentra-
tions of CSE determined by EBC pH and 100 μM H2O2
as a positive control for cell stimulation in bronchial epi-
thelial growth medium (BEGM) (Lonza Japan, Tokyo,
Japan). For pretreatment, we prepared the control
medium, 0.1, 0.5, and 1.0 mM N-acetyl cysteine (NAC)
(Sigma-Aldrich Japan, Tokyo, Japan), 0.1, 1.0, and
5.0 μg/ml anti-TNF-α antibody (mouse monoclonal IgG1
clone: R&D Systems, Inc., Minneapolis, MN, USA) in
BEGM.
Time-lapse cell imaging assay for apoptosis
To examine oxidative stress-induced epithelial cell apop-
tosis and the protective effect of the antioxidant over time,
a time-lapse cell imaging assay (IncuCyte ZOOM® system
with Cell Player™ 96-Well Kinetic Caspase-3/7 reagent:
Essen BioScience, Ltd., Tokyo, Japan) was performed.
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Caspase-3/7 reagent coupled the activated caspase-3/7
recognition motif (DEVD) to NucView™488, a DNA inter-
calating dye. When added to tissue culture medium, this
inert, non-fluorescent substrate crosses the cell membrane
where it is cleaved by activated caspase-3/7, resulting in
the release of the DNA dye and green fluorescent staining
of nuclear DNA. Kinetic activation of caspase-3/7 can be
monitored morphologically using live cell imaging, and
quantified using the IncuCyte ZOOM® Basic Analyzer or
the IncuCyte™ FLR object counting algorithm. Caspase-3/
7 reagent was diluted and added to each well for a final
concentration of 5 μM in each pretreatment media. The
96-well plate was put into a microplate tray in IncuCyte
ZOOM. The previously described pretreatment and treat-
ment media were added to each well. The IncuCyte
ZOOM acquired phase-contrast images at 3-h intervals
over a period of 12 h, and calculated the mean bright
green cell count (the Caspase-3/7 positive cell number)
from non-overlapping fluorescent images of each well
automatically [12]. At the end of the experiment, Vybrant
DyeCycle Green (VDCG: Life Technologies Japan, Tokyo,
Japan), a cell-permeant DNA-binding fluorophore, was
added and incubated for 1 h to provide an absolute (end-
point) nuclear cell count (the total cell number). We de-
fined the apoptotic index according to the following
equation:
Apoptotic index = Caspase-3/7-positive cell number/
Total cell number
Nrf2 mRNA knockdown by siRNA
To examine the protective effect of Nrf2 on oxidative
stress-induced epithelial cell apoptosis over time, A549
cells were pre-treated with Silencer® select siRNA against
Nrf2 (Life Technologies Japan, Tokyo, Japan) and Incu-
Cyte ZOOM system and Cell Player™ 96-Well Kinetic
Caspase-3/7 reagent experiments were repeated. Silen-
cer® Negative Control siRNA (Life Technologies Japan,
Tokyo, JAPAN) was used as a negative control. A549
cells were transfected with the siRNA complex with Li-
pofectamine 2000 (Life Technologies Japan, Tokyo,
Japan) according to the manufacturer’s recommenda-
tions. The knockdown efficiency of Nrf2 was quantified
by RT-PCR. The A549 cells were seeded in a 96-well
plate at a density of 1.67 × 103 cells per well in triplicate.
On the next day, cells were transfected with the siRNA
complex. Twenty-four hour later, the cells were treated
with 10 % CSE and examined the apoptotic index using
IncuCyte ZOOM.
Terminal deoxynucleotidyltransferase-mediated dUTP nick
end labelling assay (TUNEL) and DAPI staining
To confirm CSE-induced apoptosis, not just Caspase-3/7
activation, TUNEL staining (Roche Diagnostics K.K.,
Tokyo, Japan) was performed. A549 cells were grown on
culture slides and fixed in methanol and acetone. Then,
slides were incubated for 1 h at 37 °C in the presence of
terminal deoxynucleotidyl transferase (TdT). In the
negative control, no TdT was added. In addition, after
cells were washed with PBS, cells were stained with
2 μg/ml DAPI for 15 min. Slides were observed with a
fluorescent microscope at 475–495 nm for TUNEL and
330–385 nm for DAPI at × 400 magnification.
Statistical analysis
Statistical analyses were performed using JMP version
10.0.0 software for Windows (SAS Institute Inc., Cary,
NC, USA). To compare 2 groups, a t-test or paired t-test
was performed. To compare more than 3 groups, an
analysis of variance (ANOVA) followed by the Tukey–
Kramer method were performed. In all statistical ana-
lyses, p-values < 0.05 were considered significant.
Results
Nrf2 mRNA and protein level decreased in COPD subjects
Subject characteristics were shown in Table 1. There
were no significant differences in age or BMI. FEV1.0
and % FEV1 in COPD subjects were significantly lower
than those in the CTL group. Nrf2 mRNA level in
COPD subjects was significantly lower than that in the
CTL subjects (Fig. 1a). There was significant negative
correlation between Nrf2 mRNA expression and pack-
year (Fig. 1b). Nrf2 protein level in COPD subjects was
also significantly lower than that in the CTL subjects
(Fig. 1c and d). There were Nrf2 positive epithelial cells
in alveolar septum in both COPD and CTL subjects
(Fig. 2a). In addition, the ratio of positive cells to alveo-
lar septal length in COPD subjects was significantly de-
creased compared with CTL subjects (Fig. 2b).
EBC pH decreased after cigarette smoking
We measured the EBC pH in non-COPD smokers before
and after cigarette smoking. The first EBC was collected
after overnight non-smoking. They were then allowed to
smoke 1 cigarette. After 15 min of smoking, the second
Table 1 Subjects, characteristics
Control COPD p-value
Subject No. 7 8 N.S.
Sex (male/female) (2/5) (6/2)
Age (year) 62.7 (56.9–68.5) 70.0 (64.6–75.5) N.S.
BMI (kg/m2)* 22.4 (19.1–25.8) 21.2 (18.1–24.3) N.S.
Pack-Year* 0 55.9** (40.1–71.6) p < 0.01
FEV1.0 (L)* 2.40 (1.89–2.90) 1.40** (1.00–1.79) p < 0.01
% FEV1.0 (%)* 88.9 (73.4–104.4) 55.0 ** (42.8–67.3) p < 0.01
*mean (95 % confidence interval) **p < 0.05 compared with control
BMI: body mass index
FEV1.0: Forced expiratory volume in one second
% FEV1.0: percent predicted forced expiratory volume in one second
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EBC was collected. EBC pH was significantly lower after
smoking (Fig. 3). These results indicate that smoking only
1 cigarette can cause oxidative stress in the airway. To
mimic the oxidative milieu in smokers’ airways in in vitro
experiments, we measured the pH of various concentra-
tions of H2O2 and CSE diluted in PBS or culture medium.
The pH of 100 μM H2O2 was 7.54. The pH of 10 and
15 % CSE were 7.75 and 7.56, respectively. We chose 10
and 15 % CSE as treatments and 100 μM H2O2 as a posi-
tive control in in vitro experiments.
CSE-induced epithelial cell apoptosis
Following 15 % CSE treatment, green fluorescent staining
by caspase-3/7 reagent was higher than that in the control
(Fig. 4a). The apoptotic index was time-dependent and the
peak apoptotic index was recorded at 12 h after treatment
(Fig. 4b). The apoptotic index also showed CSE
concentration-dependence, and the apoptotic index of
cells treated with 15 % CSE was significantly higher that of
the control (Fig. 4c). To confirm CSE-induced apoptosis,
we performed TUNEL staining in control and 15 % CSE-
treated cells. TUNEL fluorescence was higher with 15 %
CSE-treated than in the control cells (Fig. 5).
Nrf2 knockdown increased CSE-induced epithelial cell
apoptosis
Nrf2 is a central transcription factor for the antioxidant
defense system. Oxidative stress causes apoptosis; therefore,
Fig. 1 Nrf2 expression in study subjects. a Nrf2 mRNA expression in COPD subjects were significantly decreased compared with CTL subjects.
b Nrf2 mRNA expression was significantly negatively correlated with pack-year. c Western blotting analysis of Nrf2 in bronchial epithelial cells in
COPD and CTL subjects. d The blotting were normalized to β-actin and measured by densitometry. Nrf2 protein expression in COPD subjects
were significantly decreased compared with CTL subjects. CTL: control
Fig. 2 Nrf2 immunohistochemistry. a Immunohistochemical assessment of Nrf2. (a) CTL, x100 magnification, (b) CTL, x400 magnification, (c)
COPD, x100 magnification and (d) COPD, x400 magnification. b Nrf2 expression in COPD subjects were significantly decreased compared with
CTL in immunohisotochemical assessment. CTL: control
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we examined the effect of Nrf2 knockdown on apoptosis of
A549 cells. A549 cells transfected with Nrf2 siRNA com-
plex showed significantly decreased Nrf2 mRNA level in
control conditions. Further, 15 % CSE treated A549 cells
transfected with Nrf2 siRNA complex also showed signifi-
cantly decreased Nrf2 mRNA level (Fig. 6a), mimicking
cigarette smoke-associated COPD airways. 10 % CSE treat-
ment condition and 10 % CSE treatment with Nrf2 mRNA
knockdown increased apoptotic index over time (Fig. 6b).
Althugh apoptotic index in 10 % CSE treatment was greater
than that in control conditions, the difference between the
indices did not reach statistical significance. However, the
apoptotic index in 10 % CSE with Nrf2 mRNA knockdown
was significantly greater than that in control conditions
(Fig. 6c). These results suggested that decreased Nrf2
mRNA expression increased CSE-induced apoptosis of
A549 cells.
NAC attenuated CSE-induced epithelial cell apoptosis
We investigated whether NAC protected against CSE-
induced epithelial cell apoptosis. Green fluorescent
staining by caspase-3/7 reagent in 1.0 μM NAC-
pretreated 15 % CSE cells was lower than that in 15 %
CSE-treated cells (Fig. 7a). Although pretreatment with
Fig. 3 The pH of exhaled breath condensate before and after smoking. The pH of exhaled breath condensate (EBC) before and after smoking in
non-COPD smoking subjects. The pH of EBC was significantly decreased after smoking. Data were expressed as Mean ± SEM
Fig. 4 CSE induced apoptosis. a Green fluorescent staining by caspase-3/7 reagent revealed apoptosis cells. The number of green fluorescent
staining was increased in 15 % CSE treatment. b Apoptotic index was increased over time in 10 % CSE, 15 % CSE or 100 μM H2O2 treatment
compared with CTL. *: p < 0.05 compared with CTL. c Apoptotic index increased depending on CSE concentration. Apoptotic indices in 15 % CSE,
100 μM H2O2 treatment were significantly increased compared with CTL. CTL: control
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0.1 μM NAC did not reduce the 15 % CSE-induced apop-
totic index, pretreatment with 0.5 or 1.0 μM NAC signifi-
cantly reduced the 15 % CSE-induced apoptotic index
(Fig. 7b). In contrast, pretreatment with 0.1, 1.0, or 5.0 μg/
ml anti-TNF-α antibody did not reduce the apoptotic
index of 10 or 15 % CSE-treated cells or of 100 μM H2O2-
treated cells (data not shown). These findings suggest that
CSE-induced apoptosis is caused by oxidative stress that is
not mediated by the TNF-α receptor pathway.
Discussion
In the present study, we demonstrated that Nrf2 expres-
sion in bronchial epithelial cells in COPD subjects was
significantly lower than that in control subjects. In
addition, we immunohistochemically showed that Nrf2
expression in alveolar epithelial cells was significantly
lower than that in control subjects. Nrf2 plays an im-
portant role as the master regulator of antioxidant re-
sponses [13]. Nrf2 is constitutively expressed in almost
Fig. 5 TUNEL stain in 15 % CSE treatment. DAPI (Left) and TUNEL (right) stain were performed on A549 cells after 24 h of 15 % CSE treatment or
control. Nuclei were detected with DAPI fluorescence (blue) Apoptosis were detected with TUNEL fluorescence (green). Increased TUNEL fluorescence
was observed in 15 % CSE treatment compared with control
Fig. 6 Effect of Nrf2 knock down on CSE induced apoptosis. a The siRNA-Nrf2 complex transfection with A549 cell significantly decreased Nrf2
mRNA expression in CTL and 15 % CSE. b Apoptotic index was increased over time in 10 % CSE or 10 % CSE with Nrf2 knockdown compared
with CTL. *: p < 0.05 compared with CTL. c Apoptotic index was not significantly increased in 10 % CSE compared with CTL, while significantly
increased in 10 % CSE with Nrf2 knockdown compared with CTL. CTL: control
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all cell types and tissues, and is most abundant in tissues
where detoxification reactions occur routinely, including
the lungs. However, Nrf2 is also inducible and triggered
by oxidative stress, injury, and inflammation. Cigarette
smoke contains a substantial ROS, and exposure to
cigarette smoke is known to induce transient Nrf2 ex-
pression in human airway cells. Upon stimulation, cyto-
solic Nrf2 reaches the nucleus and binds to ARE in the
upstream promoter region of antioxidant genes and ini-
tiates transcription [4]. Among these, the glutathione
cysteine ligase catalytic subunit (GCLC) and glutathione
cysteine ligase modifier subunit (GCLM) are important
for antioxidant defense. Nrf2 is required for the consti-
tutive and inducible expression of GCLC and GCLM,
which are required for glutathione (GSH) synthesis [14].
Impaired Nrf2 expression in COPD patients might fail
to evoke an appropriate antioxidant response and allow
excessive apoptosis resulting in lung tissue destruction
and emphysema. A previous cohort study showed that
certain polymorphisms of the Nrf2 gene correlated with
accelerated limitations in airflow of smokers [15, 16].
Subjects with impaired Nrf2 might be related to COPD.
Cigarette smoke causes oxidative stress, enhances
inflammation, inactivates critical anti-proteinase inhibi-
tors such as α1-antitrypsin [17], and causes apoptosis of
alveolar cells [18]. To determine the appropriate condi-
tions for in vitro CSE study, we used the pH of EBC as a
reference. Collection of EBC is a non-invasive and re-
peatable technique for monitoring the airway milieu.
EBC pH is known to correlate with oxidative stress and
H2O2 concentration [19]. A previous report observed
that the mean EBC pH in patients with COPD and non-
COPD smokers was significantly lower than that in
non-smoking subjects [20]. We measured EBC pH be-
fore and after smoking and found that the EBC pH was
immediately lowered after smoking. Our results con-
firmed that cigarette smoking caused oxidative stress in
the human airway. We chose 10 % and 15 % CSE as
treatments and 100 μM H2O2 as a positive control in
in vitro CSE experiments. We determined the effect of
oxidative stress by CSE on apoptosis over time using
IncuCyte ZOOM and showed that the apoptotic index
increased significantly at 12 h after treatment with
10 % and 15 % CSE. Because the doubling time of
A549 cell is about 22 h and in order to avoid influence
of cell division and growth, we adopted a 12-h time
point for evaluation. Although we used caspase-3/7
activation as an indicator of apoptosis, we performed
TUNEL staining to confirm apoptosis. The apoptosis
index of A549 cells increased in a CSE dose-dependent
manner. This is consistent with other in vitro studies in
BEAS-2B cells [21]. However, alveolar epithelial cells are
robustly involved in the pathogenesis of emphysema
through the alveolar wall destruction and/or the loss due to
Fig. 7 Effect of NAC pretreatment on CSE induced apoptosis. a Green fluorescent staining by caspase-3/7 reagent revealed apoptosis cells. The
number of green fluorescent staining was decreased in 15 % CSE with 1.0 mM NAC pretreatment. b Pretreatment with 0.1 mM NAC did not
decrease 15 % CSE induced apoptotic index, whereas pretreatment with 0.5, 1.0 mM NAC significantly decreased 15 % CSE induced apoptotic index
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epithelial cells apoptosis [22]. Thus, in this study we used
A549 cells, alveolar epithelial cell line, instead of BEAS-2B
cells.
Nrf2 is thought to be a key determinant of COPD suscep-
tibly [23–26]. We examined the effect of Nrf2 knockdown
on CSE-induced apoptosis. Nrf2 knockdown significantly in-
creased 10 % CSE-induced apoptosis. In previous animal
studies, Nrf2−/−mice were reported to be highly susceptible
to cigarette smoke-induced lung injury [5, 6]. On the other
hand, Nrf2 overexpression protected from cell apoptosis by
cigarette smoke exposure [27, 28]. The present results sup-
port the idea that impaired Nrf2 expression plays an import-
ant role in apoptosis. We also explored the mechanism
behind CSE-induced apoptosis. Caspase activation commits
cells to one of two distinct but convergent pathways: the
death receptor pathway and the mitochondrial pathway.
The death receptor pathway is activated when members of
the TNF-α superfamily bind to cell surface “death receptor”
members of the TNF-α receptor family. Initiators of the
mitochondrial pathway increase intracellular ROS, DNA
damage, the unfolded protein response, and the deprivation
of growth factor [29]. In the present study, we showed that
NAC ameliorates CSE-induced apoptosis. However, anti-
TNF-α antibody could not ameliorate CSE-induced apop-
tosis. CSE-induced apoptosis of A549 cells was dependent
on the mitochondrial pathway following oxidative stress and
independent of the death receptor pathway in this in vitro
setting. NAC is a precursor of GSH, which is one of the
most important antioxidants for protecting cells and tissue
from ROS. GSH and NAC act as oxygen free radical scaven-
gers [30]. GCLC, GCLM, and glutathione reductase (GR)
are also critical for GSH. Our results showed that oxidative
stress induced by CSE played a key role in apoptosis. Imbal-
ance between oxidants and antioxidants is thought to be in-
volved in the development of pulmonary emphysema [31,
32]. Thus, oxidative stress is an important therapeutic target,
and NAC is thought to be a potential drug for COPD [33–
36]. Although the BRONCUS study showed that NAC is in-
effective at preventing COPD exacerbation in patients [37],
other reports have shown that high-dose NAC significantly
reduced COPD exacerbations [38, 39]. Therapies targeting
oxidative stress are gradually showing more promising out-
comes. The limitations of this study are: (1) small number of
participants and (2) cell source (we collected epithelial cells
around the sixth branch, not the alveolar region, for tech-
nical reasons). However, the present study is an important
and extensive investigation into the relationship between
Nrf2 and oxidative stress in airway compartments of pa-
tients with COPD.
Conclusions
We demonstrated that Nrf2 expression in patients with
COPD was lower than that in control subjects, suggest-
ing that impaired Nrf2 expression might be related to
COPD. Further research into the molecular mechanisms
involved in Nrf2 expression in COPD airways and ther-
apies to upregulate Nrf2 are needed. Administration of
antioxidants to patients with COPD may be a basic
therapeutic option to consider in addition to the current
bronchodilator therapy.
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